相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Flexible Manufacturing: The Future State of Drug Product Development and Commercialization in the Pharmaceutical Industry
Yash Kapoor et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2021)
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
Alicia T. Widge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
Zoltan Kis et al.
VACCINES (2021)
A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity
Tim Beissert et al.
MOLECULAR THERAPY (2020)
Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
Sergio Linares-Fernandez et al.
TRENDS IN MOLECULAR MEDICINE (2020)
The challenge and prospect of mRNA therapeutics landscape
Yuhua Weng et al.
BIOTECHNOLOGY ADVANCES (2020)
Mannosylated Poly(ethylene imine) Copolymers Enhance saRNA Uptake and Expression in Human Skin Explants
Anna K. Blakney et al.
BIOMACROMOLECULES (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hepavac-101 first-in-man clinical trial of a multi-peptide-based vaccine for hepatocellular carcinoma
Luigi Buonaguro et al.
CANCER RESEARCH (2020)
Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
Felix S. Lichtenegger et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
mRNA Polyplexes with Post-Conjugated GALA Peptides Efficiently Target, Transfect, and Activate Antigen Presenting Cells
Bo Lou et al.
BIOCONJUGATE CHEMISTRY (2019)
Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation
Anne-Line Coolen et al.
BIOMATERIALS (2019)
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
Martin Sebastian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Giulietta Maruggi et al.
MOLECULAR THERAPY (2019)
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski et al.
MOLECULAR THERAPY (2019)
Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
Lin Xiao et al.
MOLECULAR THERAPY (2019)
Process mapping of vaccines: Understanding the limitations in current response to emerging epidemic threats
Georgina Drury et al.
VACCINE (2019)
Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes
Li-Ming Gan et al.
NATURE COMMUNICATIONS (2019)
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth et al.
NPJ VACCINES (2019)
Design of in vitro Transcribed mRNA Vectors for Research and Therapy
Marina Tusup et al.
CHIMIA (2019)
The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing
Adam C. Fisher et al.
TRENDS IN BIOTECHNOLOGY (2019)
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
Howard A. Burris et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Immunogenicity and tolerability of personalized mRNA vaccine mRNA-4650 encoding defined neoantigens expressed by the autologous cancer.
Gal Cafri et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Robert A Feldman et al.
VACCINE (2019)
A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
Markus Baiersdoerfer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Emerging Technologies for Low-Cost, Rapid Vaccine Manufacture (vol 14, 1800376, 2019)
Zoltan Kis et al.
BIOTECHNOLOGY JOURNAL (2019)
Advances in RNA Vaccines for Preventive Indications: A Case Study of a Vaccine against Rabies
Nicole Armbruster et al.
VACCINES (2019)
Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens
Cristina Poveda et al.
VACCINES (2019)
Multimodal Chromatography for Purification of Biotherapeuties - A Review
Vivek Halan et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2019)
A guide to large-scale RNA sample preparation
Lorenzo Baronti et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2018)
Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine
Hyokyoung Kwon et al.
BIOMATERIALS (2018)
Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy
Chien-Fu Hung et al.
HUMAN GENE THERAPY (2018)
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
Annette B. Vogel et al.
MOLECULAR THERAPY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
The broad socioeconomic benefits of vaccination
David E. Bloom et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446
Glenn D. Bell et al.
PLOS ONE (2018)
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch et al.
FRONTIERS IN IMMUNOLOGY (2018)
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection
Lorna Leal et al.
AIDS (2018)
Antimicrobial resistance and the role of vaccines SPECIAL FEATURE: INTRODUCTION
David E. Bloom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing
Naidi Sun et al.
SCIENTIFIC REPORTS (2018)
Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges
Heidrun Steinle et al.
STEM CELLS (2017)
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
Martin Alberer et al.
LANCET (2017)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl et al.
MOLECULAR THERAPY (2017)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
Arginine-Rich Peptide-Based mRNA Nanocomplexes Efficiently Instigate Cytotoxic T Cell Immunity Dependent on the Amphipathic Organization of the Peptide
Vimal K. Udhayakumar et al.
ADVANCED HEALTHCARE MATERIALS (2017)
Conscious coupling: The challenges and opportunities of cascading enzymatic microreactors
Pia Gruber et al.
BIOTECHNOLOGY JOURNAL (2017)
Formation and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system
Nikolay Dimov et al.
SCIENTIFIC REPORTS (2017)
Modified mRNA Vaccines Protect against Zika Virus Infection
Justin M. Richner et al.
CELL (2017)
Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA
Mengnan Zhao et al.
DRUG DELIVERY (2016)
Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial
Rajesh T. Gandhi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways
Man Li et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
mRNA capping: biological functions and applications
Anand Ramanathan et al.
NUCLEIC ACIDS RESEARCH (2016)
A general method for rapid and cost-efficient large-scale production of 5′ capped RNA
Anna-Lisa Fuchs et al.
RNA (2016)
From the RNA world to the clinic
Bruce A. Sullenger et al.
SCIENCE (2016)
Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
Jon Amund Kyte et al.
ONCOIMMUNOLOGY (2016)
The messenger's great message for vaccination
Steve Pascolo
EXPERT REVIEW OF VACCINES (2015)
The business impact of an integrated continuous biomanufacturing platform for recombinant protein production
Jason Walther et al.
JOURNAL OF BIOTECHNOLOGY (2015)
Messenger RNA-based therapeutics for the treatment of apoptosis-associated diseases
Akitsugu Matsui et al.
SCIENTIFIC REPORTS (2015)
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Hubert Kuebler et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
History of vaccination
Stanley Plotkin
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty et al.
CANCER IMMUNOLOGY RESEARCH (2014)
RNA: The new revolution in nucleic acid vaccines
Andrew J. Geall et al.
SEMINARS IN IMMUNOLOGY (2013)
Challenges and advances towards the rational design of mRNA vaccines
Charlotte Pollard et al.
TRENDS IN MOLECULAR MEDICINE (2013)
A novel, disruptive vaccination technology Self-adjuvanted RNActive® vaccines
Karl-Josef Kallen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption
Sabine D. Allard et al.
CLINICAL IMMUNOLOGY (2012)
The current challenges for vaccine development
Petra Oyston et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
Benjamin Petsch et al.
NATURE BIOTECHNOLOGY (2012)
Developing mRNA-vaccine technologies
Thomas Schlake et al.
RNA BIOLOGY (2012)
Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
M. Diken et al.
GENE THERAPY (2011)
The development of vaccines: how the past led to the future
Stanley A. Plotkin et al.
NATURE REVIEWS MICROBIOLOGY (2011)
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
Katalin Kariko et al.
NUCLEIC ACIDS RESEARCH (2011)
Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
Sebastian Kreiter et al.
CANCER RESEARCH (2010)
Rapid, nondenaturing RNA purification using weak anion-exchange fast performance liquid chromatography
Laura E. Easton et al.
RNA (2010)
Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Vaccination greatly reduces disease, disability, death and inequity worldwide
F. E. Andre et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Results of the first phase I/II clinical vaccination trial with direct injection of mRNA
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent
J. Probst et al.
GENE THERAPY (2007)
Rapid purification of RNAs using fast performance liquid chromatography (FPLC)
Insil Kim et al.
RNA (2007)
Purification and characterization of transcribed RNAs using gel filtration chromatography
Sean A. McKenna et al.
NATURE PROTOCOLS (2007)
Messenger RNA-based vaccines
S Pascolo
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Large-scale preparation and purification of polyacrylamide-free RNA oligonucleotides
PJ Lukavsky et al.
RNA (2004)
分享论文
